Sherwin-Williams Co., Merck Share Gains Lead Dow's Nearly 300-Point Jump

Dow Jones
3 hours ago

DJ Sherwin-Williams Co., Merck Share Gains Lead Dow's Nearly 300-Point Jump

This article was automatically generated by MarketWatch using technology from Automated Insights.

Behind positive gains for shares of Sherwin-Williams Co. and Merck, the Dow Jones Industrial Average is climbing Wednesday afternoon.

Shares of Sherwin-Williams Co. (Sherwin-Williams Co.) and Merck (Merck & Co. Inc.) are contributing to the blue-chip gauge's intraday rally, as the Dow (Dow Jones Industrial Average) was most recently trading 295 points, or 0.6%, higher.

Sherwin-Williams Co.'s shares are up $7.67 (2.5%) while those of Merck are up $2.68 (2.3%), combining for an approximately 64-point bump for the Dow.

Honeywell (Honeywell International Inc.), Johnson & Johnson (Johnson & Johnson), and Amazon.com Inc. (Amazon.com Inc.) are also contributing significantly to the gain.

A $1 move in any of the benchmark's 30 components equates to a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 25, 2026 14:55 ET (18:55 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10